Anturane

Anturane

 [an´tu-rān]
trademark for a preparation of sulfinpyrazone, a uricosuric agent used in the management of gout.
References in periodicals archive ?
A sixth agent, sulfinpyrazone (Anturane), a uricosuric agent, has been withdrawn from the market, but there are no reports describing its use to treat gout in pregnant women.
Perhaps the most famous case dates back to 1978, when The New England Journal of Medicine reported that Ciba-Geigy's gout drug Anturane had been found to reduce the incidence of fatal heart attacks in people who had suffered at least one previous heart attack.
The AWP of a month supply of brand name (Anturane) and generic sulfinpyrazone in 1991 was $48.25 and $28.45, respectively (Medical Economics Company 1991).